Factors associated with osteoporosis in patients with chronic obstructive pulmonary disease—a nationwide retrospective study
Authors:
- 12 August 2016
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 28 (1) , 359-367
Abstract
Summary The present study aimed to identify the factors associated with osteoporosis in patients with chronic obstructive pulmonary disease in Taiwan. The study found that female sex, old age, and use of a high dose of oral corticosteroids were significantly associated with osteoporosis in these patients. Introduction Chronic obstructive pulmonary disease (COPD) is becoming an increasingly serious and prevalent issue worldwide. The treatment of COPD with long-term steroid use may cause osteoporosis and have significant influences on disability and mortality. However, few studies have evaluated the association between steroid use and osteoporosis in patients with COPD. The present study aimed to identify the factors, including demographic characteristics and steroid use (oral corticosteroids [OCSs], inhaled corticosteroids, and injected steroids), associated with osteoporosis in patients with COPD in Taiwan. Methods This was a retrospective case-control study. Data were obtained from the National Health Insurance Research Database from 1997 to 2009. Cox proportional hazard regression models were used to identify the factors associated with osteoporosis. Results The incidence of osteoporosis in the patients with COPD was 1343.0 per 100,000 person-years, the majority of patients were women (63.6 %), and the mean age of the patients was 72.5 years. In multivariate regression analysis, female sex, old age, and use of a high OCS dose with a defined daily dose (DDD) >56 (hazard ratio 1.85, 95 % confidence interval 1.52–2.26, P < .0001) exhibited significant independent associations with osteoporosis. Conclusions Female sex, old age, and use of a high OCS dose with a cumulative DDD >56 are associated with osteoporosis in patients with COPD. Additionally, female patients >50 years old and male patients >70 years old have a higher risk of osteoporosis. Medical personnel should actively provide health education for the prevention of osteoporosis in these patients.Keywords
Funding Information
- Chang Gung Medical Foundation (CORPG6D0161, CORPF6D0021)
- National Science Council (101-2410-H-255 -002)
This publication has 20 references indexed in Scilit:
- Increased risk and related factors of depression among patients with COPD: a population-based cohort studyBMC Public Health, 2013
- Prescription Patterns of Chinese Herbal Products for Osteoporosis in Taiwan: A Population-Based StudyEvidence-Based Complementary and Alternative Medicine, 2012
- Osteoporosis Prevalence and Associated Factors in Patients With COPD: A Cross-Sectional StudyRespiratory Care, 2011
- Skeletal health in men with chronic lung disease: rates of testing, treatment, and fracturesOsteoporosis International, 2010
- Osteoporosis Risk in Patients With Chronic Obstructive Pulmonary Disease: The EOLO StudyJournal of Clinical Densitometry, 2009
- Secondary Osteoporosis: A Review of The Recent EvidenceEndocrine Practice, 2006
- Secondary OsteoporosisJournal of the American Academy of Orthopaedic Surgeons, 2005
- Secondary osteoporosisEndocrinology and Metabolism Clinics of North America, 2003
- Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary diseaseEuropean Respiratory Journal, 2003
- Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trialBMJ, 2000